ANAGENICS LIMITED (AN1)

---

AI Coverage Rating: Active

ASX AI Signals has generated 3 signal for AN1 during the last 90 days, indicating active trading activity and ongoing AI monitoring

Latest AN1 Signals
26/06/2026	BUY
25/06/2026	SELL
18/06/2026	BUY
AN1 Share Price
Current Price	$0.007
52 Week High	$0.009
52 Week Low:	$0.004
Trading at (% of 52 Week High)	77.78%

Business Overview

Anagenics Limited (ASX: AN1) is an Australian biotechnology company that specializes in developing medical solutions for tissue repair and wound healing. The company focuses on advanced therapies and products designed to improve skin and tissue regeneration.

ASX Sector Overview

Sector:   Pharmaceuticals, Biotechnology & Life Sciences

The Pharmaceuticals, Biotechnology & Life Sciences sector on the ASX includes companies involved in the development, production, and commercialization of drugs, medical devices, and biotechnology products. This sector covers activities such as research and development of new medicines, genetic testing, and innovative healthcare technologies. Companies often work on treatments for diseases, including cancer, infectious diseases, and chronic conditions. The sector plays a crucial role in advancing medical science and improving patient care through innovation.

Latest AI Recommendation

The BUY signal for ANAGENICS LIMITED at a very low price point suggests potential upside, but the overall confidence remains low due to limited market capitalization, liquidity concerns, and lack of substantial fundamental data.

Latest  ANAGENICS LIMITED(AN1)   News